medigraphic.com
Colegio de Medicina Interna de México.

2012, Number 5

<< Back Next >>

Med Int Mex 2012; 28 (5)

Prescription and Subsequent Application to a System of Drug Monitoring in Internal Medicine at the Hospital General Dr. Miguel Silva (Morelia, Mexico)

Mejía SA, Rodríguez BA

Language: Spanish
References: 16
Page: 415-419
PDF size: 210.10 Kb.


ABSTRACT

The accurate medical records avoid omissions and incomplete notes and / or mistaken notes, which contributes also to avoid a current problem within the hospitals called Medication Errors (ME), often caused because the low quality of the clinical files according to the NOM- 168-SSA-1998 and therefore a poor medical attention to the patient, causing adverse drug reactions or even death and the possibility of lawsuits against people related to the health care. The aim of this study was to identify if there is a difference between registration and implementation of prescription drugs before and after the implementation of a drug monitoring system in the internal medicine specialty, it was developed in two periods with three years of difference between each one; the study was retrospective, descriptive and transversal and was realized in General Hospital "Dr. Miguel Silva "in the city of Morelia Michoacán. It included 107 medical indications from complete clinical records of October 2006 and 99 from January 2009; bearing in mind medicines prescribed but not applied, and applied medicines that were not prescribed as well. Incompatibility was found among the records of clinical prescription and implementation by nursing staff in both studied periods. However, the comparison between the first and the last period shows a significant difference of χ2 (P = ‹0.0001), therefore is possible to assume that once and after the Pharmacological Vigilance System was introduced the mentioned incompatibility decreased, which suggests that after implementation of drug monitoring system this incompatibility decreased, providing an improved quality of patient care, as demonstrated by some authors in similar studies. The drugs involved in these two situations prevailed antibiotics, diuretics, NSAIDs and inhibitors of proton pump.


REFERENCES

  1. Warholak TL, Queiruga C, Roush R, Phan H. Medication error identification rates by pharmacy, medical and nursing students. Am J Pharm Educ 2011;75(2):24.

  2. F.D.A. United States Food and Drugs administration “Medication error reports”. Disponible en http://www.fda.gov/Drugs/ DrugSafety/MedicationErrors/ucm080629.htm.

  3. Medication Errors. FDA 101: Consumer Health Information. Disponible en http://www.fda.gov/downloads/ForConsumers/ ConsumerUpdates/UCM143038.pdf

  4. Brennan TA, Leape LL, Laird N, et al. Incidence of adverse events and negligence in hospitalized patients: results from the Harvard Medical Practice Study I. N Engl J Med. 1991; 324:370-376.

  5. FDA’S safe use initiative collaborating to reduce preventable harm from medications. U.S. Department of Health and Human Services Food and Drug Administration November 4, 2009.

  6. National Coordinating Council for Medication Error Reporting and Prevention. What is a Medication Error? Disponible en http://www.nccmerp.org/aboutMedErrors.html

  7. Lavalle A, Payro–Cheng T, Martínez–Cervantes K, Torres– Narváez P, Hernández–Delgado L, Flores–Nava G. El error médico en la prescripción de medicamentos y el impacto de una intervención educativa. Bol Med Hosp Infant Mex 2007;64(2):83-90.

  8. Norma Oficial Mexicana NOM-168-SSA1-1998, del expediente clínico. Disponible en http://www.salud.gob.mx/unidades/cdi/ nom/168ssa18.html

  9. Organización Mundial de la Salud (OMS) Nota descriptiva N° 338 Mayo de 2010. Disponible en http://www.who.int/mediacentre/ factsheets/fs338/es/index.html.

  10. Juárez-Holguin H y col. Perfil de consumo de antibióticos en un hospital pediatríco de la ciudad de México. Perinatol Reprod Hum 1998;12:157-162.

  11. Leape L., Culle Dempsey M, Demonaco H. Pharmacist participation on Physician Rounds and adverse drug events. JAMA 1999;281(3):267-270.

  12. Sicras Mainar A, Peláez de Loño J. Mejora de la adecuación de uso de medicamentos y efectos en centros geriátricos mediante un programa de intervención. Farm Hosp 2005;5:303-311.

  13. Bates DW, Cullen D, Laird N, et al. Incidence ofadverse drug events and potential adverse drug events: implications for prevention. JAMA. 1995;274:29-34.

  14. Bates DW, Boyle DL, Vander Vliet MB, Schneider J, Leape LL. Relationship between medication errors and adverse drug events. J Gen Intern Med 1995;10:199-205.

  15. Bateman D, Colin-Jones D, Hartz S, Langman M, Logan R, et al. Mortality study of 18,000 patients treated with omeprazole. Gut 2003;52:942-946.

  16. Wirtz Jveronika, et al. Medicines in Mexico, 1990-2004: systematic review of research on access and use. Salud Pública de México 2008;50(4):470-479.




2020     |     www.medigraphic.com